Osteoprotegerin, thiazolidinediones treatment, and silent myocardial ischemia in type 2 diabetic patients.
Sultan
Ariane
A
Service des Maladies Métaboliques, CHU Montpellier, Hôpital Lapeyronie, Montpellier, France.
Avignon
Antoine
A
Galtier
Florence
F
Piot
Christophe
C
Mariano-Goulart
Denis
D
Dupuy
Anne Marie
AM
Cristol
Jean Paul
JP
D000367:Age Factors; D000368:Aged; D001794:Blood Pressure; D015992:Body Mass Index; D016022:Case-Control Studies; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications*; D053244:Osteoprotegerin / Q000097:blood*; D012737:Sex Factors; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003404:Creatinine; D006442:Glycated Hemoglobin; D053244:Osteoprotegerin; D045162:Thiazolidinediones; D014280:Triglycerides; C517652:hemoglobin A1c protein, human